Effects on Experimental Dyspnea of High Flow Nasal Cannula
NCT ID: NCT03469037
Last Updated: 2019-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2018-05-22
2018-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients
NCT07308171
Benefits of High Flow Nasal Cannula Oxygen for Preoxygenation During Intubation in Non Severely Hypoxemic Patients
NCT02700321
High Flow Nasal Cannula Versus Non-Invasive Ventilation in Exacerbations of Chronic Obstructive Pulmonary Disease
NCT03033251
Role of High Flow Nasal Oxygen as a Strategy for Weaning From Invasive Mechan
NCT04657796
The Effects of Flow Settings During High Flow Nasal Cannula for Adult Hypoxemia Patients
NCT03738345
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study will also compare the effects on dyspnea of the administration of high flow nasal cannula with and without oxygen added.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxygen first
Optiflow with an inspired fraction of oxygen of 100% in the first seance Optiflow with an inspired fraction of oxygen of 21 % in the second seance
Optiflow with an inspired fraction of oxygen of 100%
Respiratory gaz heated and humidified system of delivery with a fraction of oxygen inspired of 100%
Optiflow with an inspired fraction of oxygen of 21%
Respiratory gaz heated and humidified system of delivery with a fraction of oxygen inspired of 21%
Air first
Optiflow with an inspired fraction of oxygen of 21 % in the first seance Optiflow with an inspired fraction of oxygen of 100 % in the second seance
Optiflow with an inspired fraction of oxygen of 100%
Respiratory gaz heated and humidified system of delivery with a fraction of oxygen inspired of 100%
Optiflow with an inspired fraction of oxygen of 21%
Respiratory gaz heated and humidified system of delivery with a fraction of oxygen inspired of 21%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optiflow with an inspired fraction of oxygen of 100%
Respiratory gaz heated and humidified system of delivery with a fraction of oxygen inspired of 100%
Optiflow with an inspired fraction of oxygen of 21%
Respiratory gaz heated and humidified system of delivery with a fraction of oxygen inspired of 21%
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* active smokers
* anxiety disorder
* allergy to latex
* protected adult
* woman declared herself pregnant
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Capucine Morelot-Panzini, Doctor
Role: PRINCIPAL_INVESTIGATOR
Service de Pneumologie de la Pitié-Salpétrière
Thomas Similowski, PHD
Role: STUDY_DIRECTOR
Service de Pneumologie de la Pitié-Salpétrière
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laboratoire de Physiopathologie Respiratoire du Service de Pneumologie et de Réanimation
Paris, , France
Service de Pneumologie et Réanimation Médicale
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A00178- 47
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.